We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Image Scan Holdings Plc | LSE:IGE | London | Ordinary Share | GB0031410581 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.35 | 1.20 | 1.50 | 1.35 | 1.35 | 1.35 | 8,180 | 07:36:25 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Photographic Equip & Supply | 2.96M | 124k | 0.0009 | 15.00 | 1.85M |
Date | Subject | Author | Discuss |
---|---|---|---|
19/11/2019 13:36 | Well there you go, rather a mischievous exaggeration! Made it sound like head technologist was ill not had an accident and was already back in part time ! Chief Software engineer? No , a team member but not the grand fromage at all. So why would you want to stir things up Msr Reynard. Not Renard then or would that be too obvious! Vive le difference! | assagai | |
19/11/2019 13:01 | Don't know Monty but this guy only joined ADVFN today so likely an insider? I will call Bill. | assagai | |
19/11/2019 12:28 | Where did this information come from | monty68 | |
19/11/2019 08:45 | Curious. Chief software guy leaves and head Technologist long term sick. Price goes up. Well that's AIM for you. | reynard4 | |
18/11/2019 10:15 | Appologies for the earlier company mix up. I follow both IGE and IQE. | plutonian | |
18/11/2019 10:01 | Well done Bill. Wish I knew why though. | paleje | |
18/11/2019 09:32 | Volume's keen | owenski | |
18/11/2019 09:29 | Well on its way now and a great Monday morning start. | clocktower | |
18/11/2019 09:12 | LOL! That TU is for IQE! | soldi | |
18/11/2019 09:08 | No - wrong co! That's IQE not IGE! | philjeans | |
18/11/2019 08:59 | [edit - sorry wrong company] Trading update out... | plutonian | |
18/11/2019 08:44 | Going well today again - been tipped? | philjeans | |
15/11/2019 15:01 | Not much chance of death Assagai, all the signals seem positive, and I expect to see this at least double again in the near future. | clocktower | |
15/11/2019 14:53 | SP back to where it was in 2016 If they can get on and just sell product then this'll still look cheap. Time will tell. imo | owenski | |
15/11/2019 14:37 | I guess it's do or die...... | assagai | |
15/11/2019 14:26 | Brave man, Assagai. I have too many to think of adding more, and I don't suppose i have a small fraction of your holding! | gnnmartin | |
15/11/2019 14:22 | I have☺️ | assagai | |
15/11/2019 13:05 | More deals in the pipeline? Good time to add. | philjeans | |
15/11/2019 13:01 | About time too | monty68 | |
15/11/2019 12:27 | This insists on going up admittedly on weak volume, doubled since early Oct. | paleje | |
29/10/2019 16:46 | Hopefully not long before the next leg up. | clocktower | |
27/10/2019 16:33 | Please see SKIN - about to move up. 1) Laboratory grown human skin that can be tested on, instead of testing on animals 2) Only commercially available option of its type. 3) Exploiting high growth technologies such as Artificial Intelligence 4) Human skin cloning duplicates test subjects 5) It is an Ethical investment 6) Exploiting CBD market 7) Cutting edge Woundcare -Visual diagnostic wound dressing that changes colour to indicate infection or improvement of the wound under the dressing. 8) Expanding laboratory space by 100% to accommodate the rate of growth due to be RNS any day 9) Currently negotiating further contracts. (8 CBD we know of and others) due to be RNS soon 10) Fully funded - The growth of the Company has been so well supported and received by the market that all corporate activity has been achieved, funding in place to accommodate the continued growth. 11) Meeting its objective of increasing the average revenue per client as it evolves into a multiple revenue stream product and services company 12) Four Blue-Chip (US and EU) client agreements signed 13) owns 9.35% of Cellulac plc 14) Algzym - A patented enzyme-based technology which bursts algal cell walls and releases Omega 3 oils in a simple solvent-free process. 15) Company moving forward at a rapid pace. 16) Major relationships already built with billion-dollar companies 17) Sales routes for products already in place in multiple countries 18) EU laws changing to force companies to stop beauty and pharmaceuticals testing on animals. 19) EU laws changing to force companies to stop making claims they can't back up scientifically. 20) EU laws changing to force companies to comply with more rigorous testing before market launch. 21) Presenting at major US and European Skin and Dermatology events 22) Presenting at major CBD Exhibitions 23) Strong, dynamic and driven board 24) CEO is an owner of company/major investor The chart is primed for a great entry' hxxps://www.labskin. | lisae123 | |
26/10/2019 00:07 | No, good point Assagai. Whilst I think the closed period only strictly relates to insider trading, you're probably right, probably not likely to release any further contract news until the results.So six weeks or so of speculation and rumour. :o) | laugher | |
25/10/2019 22:55 | We won't find anything out on Monday I'm afraid apart from how long the Brexit extension is! Remember the last update was a "pre close" trading statement I. E. We are now in a closed period.... | assagai |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions